PMD - Psychemedics Corp Stock Price, Fair Value and News

$2.01+0.04 (+2.03%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

PMD Price Action

Last 7 days

1.0%


Last 90 days

-14.5%


Trailing 12 Months

-36.9%

PMD RSI Chart

MayJunJulAugSepOctNovDec202530405060708090

PMD Valuation

Market Cap

11.8M

Price/Earnings (Trailing)

-3.94

Price/Sales (Trailing)

0.58

EV/EBITDA

-3.54

Price/Free Cashflow

23.92

PMD Price/Sales (Trailing)

20222023202420250.511.52

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PMD Fundamentals

PMD Revenue

Revenue (TTM)

20.3M

Rev. Growth (Yr)

-9.27%

Rev. Growth (Qtr)

9.45%

2010201220142016201820202022202420M25M30M35M40M

PMD Earnings

Earnings (TTM)

-3.0M

Earnings Growth (Yr)

74.51%

Earnings Growth (Qtr)

35.31%

20102012201420162018202020222024-4M-2M02M4M6M8M

PMD Profitability

EBT Margin

-14.57%

Return on Equity

-54.99%

Return on Assets

-30.45%

Free Cashflow Yield

4.18%

PMD Investor Care

Dividend Yield

10.34%

Dividend/Share (TTM)

0.18

Shares Dilution (1Y)

1.60%

Revenue Breakdown

As of: Sep 30, 2024
Testing
ProductValuePercent
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202421.6M20.8M20.3M0
202324.6M23.6M22.8M22.1M
202225.7M26.1M26.0M25.2M
202119.5M22.3M23.8M24.9M
202035.4M29.4M24.7M21.4M
201941.6M40.1M38.9M37.7M
201840.4M41.5M42.5M42.7M
201742.5M42.5M40.7M39.7M
201626.9M29.6M34.4M39.0M
201528.9M28.2M27.6M27.0M
201427.5M28.3M28.9M29.2M
201325.4M25.4M26.0M26.9M
201224.3M25.0M25.1M25.2M
201121.6M22.5M23.7M24.1M
2010018.0M19.1M20.1M
200900017.0M
Get all data in R, Python etc through our Historical Stock Data APIs
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, Fentanyl, and alcohol. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
 CEO
 WEBSITEpsychemedics.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES133

Psychemedics Corp Frequently Asked Questions


What is the ticker symbol for Psychemedics Corp? What does PMD stand for in stocks?

PMD is the stock ticker symbol of Psychemedics Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Psychemedics Corp (PMD)?

As of Thu Jan 30 2025, market cap of Psychemedics Corp is 11.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PMD stock?

You can check PMD's fair value in chart for subscribers.

Is Psychemedics Corp a good stock to buy?

The fair value guage provides a quick view whether PMD is over valued or under valued. Whether Psychemedics Corp is cheap or expensive depends on the assumptions which impact Psychemedics Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PMD.

What is Psychemedics Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jan 30 2025, PMD's PE ratio (Price to Earnings) is -3.94 and Price to Sales (PS) ratio is 0.58. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PMD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Psychemedics Corp's stock?

In the past 10 years, Psychemedics Corp has provided -0.182 (multiply by 100 for percentage) rate of return.